Search Ontology:
ChEBI
alpha-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp
- Term ID
- CHEBI:146544
- Synonyms
-
- (2S,3S,4R,5S,6S)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
- 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
- 6-deoxy-alpha-L-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
- alpha-L-fucopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
- Fuc(a1-4)Gal(b1-4)Glc
- Definition
- A trisaccharide that is lactose in which the hydroxy group at position 4 of the galactose ring has been converted into its α-L-fucopyranosyl derivative.
- References
-
- glygen:G03332JB
- glytoucan:G03332JB
- kegg.glycan:G03483
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Phenotype where environments contain alpha-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Phenotype modified by environments containing alpha-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Phenotype affecting alpha-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Human Disease Model